Washington, Nov 6 : In a new study, scientists have found that a therapy targeting a protein, called cyclin D1, may block the expansion of breast cancer stem cells.
The study shows how stem cell expansion in breast cancer (called Notch activity) takes place.
Breast cancer stem cells are known to be involved in therapy resistance and the recurrence of cancerous tumours.
Headed by Dr. Richard Pestell and colleagues at Thomas Jefferson University, the study was the first to show that cyclin d1 is required for breast cancer growth in mice.